PURPOSE: The purpose of this study was to characterize the solubilization and precipitation characteristics of a range of poorly water-soluble drugs during the in vitro digestion of long-chain or medium-chain triglyceride (TG) lipid suspension formulations. METHODS: TG suspensions of model drugs (present at double their equilibrium solubilities in the respective lipid) were digested in vitro and the drug solubilization and precipitation pattern in the resulting digests analyzed. RESULTS: For griseofulvin, diazepam, and danazol, solubilization of the small mass of drug originally presented in the TG lipid was efficient with only a small proportion of the dose precipitating and being recovered in the pellet phase after digestion of the TG lipid. For the more lipophilic and lipid-soluble drugs (cinnarizine, halofantrine), in which higher drug loadings were possible, significant enhancement in drug solubilization in the postdigestion aqueous phase was not apparent compared with simple TG lipid solutions. CONCLUSIONS: Suspensions of drugs, which are poorly soluble in water and TG lipid, may prove beneficial as the relatively high solubilizing capacity of the colloidal phases produced on TG digestion will likely exceed the mass of drug that could have been administered as a simple lipid solution. However, for more lipid-soluble drugs, suspension formulations may offer little benefit as sufficiently high drug loadings can otherwise be achieved with simple solution formulations that still provide for adequate solubilization after TG digestion.
PURPOSE: The purpose of this study was to characterize the solubilization and precipitation characteristics of a range of poorly water-soluble drugs during the in vitro digestion of long-chain or medium-chain triglyceride (TG) lipid suspension formulations. METHODS:TG suspensions of model drugs (present at double their equilibrium solubilities in the respective lipid) were digested in vitro and the drug solubilization and precipitation pattern in the resulting digests analyzed. RESULTS: For griseofulvin, diazepam, and danazol, solubilization of the small mass of drug originally presented in the TGlipid was efficient with only a small proportion of the dose precipitating and being recovered in the pellet phase after digestion of the TGlipid. For the more lipophilic and lipid-soluble drugs (cinnarizine, halofantrine), in which higher drug loadings were possible, significant enhancement in drug solubilization in the postdigestion aqueous phase was not apparent compared with simple TGlipid solutions. CONCLUSIONS: Suspensions of drugs, which are poorly soluble in water and TGlipid, may prove beneficial as the relatively high solubilizing capacity of the colloidal phases produced on TG digestion will likely exceed the mass of drug that could have been administered as a simple lipid solution. However, for more lipid-soluble drugs, suspension formulations may offer little benefit as sufficiently high drug loadings can otherwise be achieved with simple solution formulations that still provide for adequate solubilization after TG digestion.
Authors: Shui-Mei Khoo; Richard J Prankerd; Glenn A Edwards; Christopher J H Porter; William N Charman Journal: J Pharm Sci Date: 2002-03 Impact factor: 3.534
Authors: Matthew F Crum; Natalie L Trevaskis; Hywel D Williams; Colin W Pouton; Christopher J H Porter Journal: Pharm Res Date: 2015-12-24 Impact factor: 4.200
Authors: Cynthia K Brown; Horst Dieter Friedel; Amy R Barker; Lucinda F Buhse; Susanne Keitel; Todd L Cecil; Johannes Kraemer; J Michael Morris; Christos Reppas; Mary P Stickelmeyer; Chikako Yomota; Vinod P Shah Journal: AAPS PharmSciTech Date: 2011-06-18 Impact factor: 3.246
Authors: André Brodkorb; Lotti Egger; Marie Alminger; Paula Alvito; Ricardo Assunção; Simon Ballance; Torsten Bohn; Claire Bourlieu-Lacanal; Rachel Boutrou; Frédéric Carrière; Alfonso Clemente; Milena Corredig; Didier Dupont; Claire Dufour; Cathrina Edwards; Matt Golding; Sibel Karakaya; Bente Kirkhus; Steven Le Feunteun; Uri Lesmes; Adam Macierzanka; Alan R Mackie; Carla Martins; Sébastien Marze; David Julian McClements; Olivia Ménard; Mans Minekus; Reto Portmann; Cláudia N Santos; Isabelle Souchon; R Paul Singh; Gerd E Vegarud; Martin S J Wickham; Werner Weitschies; Isidra Recio Journal: Nat Protoc Date: 2019-03-18 Impact factor: 13.491
Authors: Christopher J H Porter; Ann Marie Kaukonen; Ben J Boyd; Glenn A Edwards; William N Charman Journal: Pharm Res Date: 2004-08 Impact factor: 4.200